The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

Researchers now understand how soybean oil is linked to obesity. The study could affect HHS Sec. RFK Jr.'s new food regulations.

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

Gut microbes link obesity and colon cancer. Diet can shift these microbes fast. Simple changes may lower risk and improve future treatments.

The gut microbiome serves as both a biomarker and therapeutic target in diseases like obesity, metabolic syndrome, and ...

Marketers are positioning weight-loss shots as cosmetic elixirs for anyone who wants to lose a few pounds. Doctors warn that ...

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

A well-planned public health agenda that incorporates GLP-1 drugs has the potential to reduce obesity rates, increase life ...

Aim to go on a walk within an hour of eating your Thanksgiving meal, according to the University of Washington. Blood sugar ...

Experts argue there is no standard definition of metabolically healthy obesity, and most people convert over time to ...

Obesity is one of the most common and complex chronic diseases clinicians encounter in practice. Yet it is still often ...

A large analysis of more than 11 million medical records found that people with untreated obstructive sleep apnea face a substantially higher risk of developing Parkinson’s disease over time.